English
Segment disclosures
Company overviewAMERICAN SHARED HOSPITAL SERVICES
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
4 dimension combinations 80 retained observations 24 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Direct Patient Services
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ams:DirectPatientServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 4885000 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 8949000 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 4064000 | USD | 20260514 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 15529000 | USD | 20260331 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 4034000 | USD | 20260116 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 10655000 | USD | 20260116 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3500000 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 6621000 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3121000 | USD | 20260514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 12556000 | USD | 20260331 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3687000 | USD | 20260116 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 7807000 | USD | 20260116 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3157000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4120000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 963000 | USD | 20250515 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3553000 | USD | 20250404 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 988000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2440000 | USD | 20241114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 756000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1452000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 696000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3091000 | USD | 20240401 | Open filing evidence |
Domestic Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ams:DomesticSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 4146000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 13187000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 4812000 | USD | 20230814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 9041000 | USD | 20230814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4229000 | USD | 20230512 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 16655000 | USD | 20230331 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 4101000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 12382000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 4140000 | USD | 20230814 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 8281000 | USD | 20230814 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 4141000 | USD | 20230512 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 14719000 | USD | 20230331 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 3477000 | USD | 20221110 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 10892000 | USD | 20221110 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 7415000 | USD | 20220815 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 3699000 | USD | 20220512 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 16204000 | USD | 20220330 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 910000 | USD | 20211110 | Open filing evidence |
Foreign Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ams:ForeignSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 988000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2440000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 756000 | USD | 20230814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1452000 | USD | 20230814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 696000 | USD | 20230512 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3091000 | USD | 20230331 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 727000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2327000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 894000 | USD | 20230814 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1600000 | USD | 20230814 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 706000 | USD | 20230512 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2909000 | USD | 20230331 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 622000 | USD | 20221110 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 2047000 | USD | 20221110 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1425000 | USD | 20220815 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 665000 | USD | 20220512 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 1633000 | USD | 20220330 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 12319000 | USD | 20211110 | Open filing evidence |
Medical Equipment Leasing
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ams:MedicalEquipmentLeasingMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 3545000 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 6565000 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 3020000 | USD | 20260514 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 12553000 | USD | 20260331 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3137000 | USD | 20260116 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 9699000 | USD | 20260116 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3571000 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 6562000 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2991000 | USD | 20260514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 15784000 | USD | 20260331 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3312000 | USD | 20260116 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 11464000 | USD | 20260116 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3899000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 8152000 | USD | 20250813 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4253000 | USD | 20250515 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 17772000 | USD | 20250404 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4146000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 13187000 | USD | 20241114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 4812000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 9041000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4229000 | USD | 20240515 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 16655000 | USD | 20240401 | Open filing evidence |